200 related articles for article (PubMed ID: 23946517)
1. Application of a newly developed high-sensitivity HBsAg chemiluminescent enzyme immunoassay for hepatitis B patients with HBsAg seroclearance.
Shinkai N; Matsuura K; Sugauchi F; Watanabe T; Murakami S; Iio E; Ogawa S; Nojiri S; Joh T; Tanaka Y
J Clin Microbiol; 2013 Nov; 51(11):3484-91. PubMed ID: 23946517
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the highly sensitive chemiluminescent enzyme immunoassay "Lumipulse HBsAg-HQ" for hepatitis B virus screening.
Deguchi M; Kagita M; Yoshioka N; Tsukamoto H; Takao M; Tahara K; Maeda I; Hidaka Y; Yamauchi S; Kaneko A; Miyakoshi H; Isomura M
J Clin Lab Anal; 2018 May; 32(4):e22334. PubMed ID: 28984383
[TBL] [Abstract][Full Text] [Related]
3. [Clinical evaluation of a newly developed high-sensitive detection of hepatitis B virus surface antigen by a semi-automated immune complex transfer chemiluminescent enzyme immunoassay].
Ohne K; Kani S; Ohashi M; Shinkai N; Inoue T; Wakimoto Y; Tanaka Y
Rinsho Byori; 2013 Sep; 61(9):787-94. PubMed ID: 24369590
[TBL] [Abstract][Full Text] [Related]
4. Novel monitoring of hepatitis B reactivation based on ultra-high sensitive hepatitis B surface antigen assay.
Shinkai N; Kusumoto S; Murakami S; Ogawa S; Ri M; Matsui T; Tamori A; Toyoda H; Ishida T; Iida S; Tanaka Y
Liver Int; 2017 Aug; 37(8):1138-1147. PubMed ID: 27992664
[TBL] [Abstract][Full Text] [Related]
5. Highly sensitive detection of hepatitis B virus surface antigen by use of a semiautomated immune complex transfer chemiluminescence enzyme immunoassay.
Takeda K; Maruki M; Yamagaito T; Muramatsu M; Sakai Y; Tobimatsu H; Kobayashi H; Mizuno Y; Hamaguchi Y
J Clin Microbiol; 2013 Jul; 51(7):2238-44. PubMed ID: 23658266
[TBL] [Abstract][Full Text] [Related]
6. Performance evaluation of HBsAg by Lumipulse HBsAg-HQ: The agreement with HBsAg by Architect HBsAg-QT and the effectiveness in predicting liver tissue pathological states of chronic hepatitis B patients.
Zhang Z; Ding R; Lu W; Yang Z; Wang Y; Zhou X; Huang D; Li X; Feng Y
Adv Clin Exp Med; 2018 Aug; 27(8):1045-1054. PubMed ID: 29893514
[TBL] [Abstract][Full Text] [Related]
7. An improved Abbott ARCHITECT assay for the detection of hepatitis B virus surface antigen (HBsAg).
Lou SC; Pearce SK; Lukaszewska TX; Taylor RE; Williams GT; Leary TP
J Clin Virol; 2011 May; 51(1):59-63. PubMed ID: 21367654
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a novel chemiluminescent microplate enzyme immunoassay for hepatitis B surface antigen detection.
Yang L; Song LW; Fang LL; Wu Y; Ge SX; Li H; Yuan Q; Zhang J; Xia NS
J Virol Methods; 2016 Feb; 228():55-9. PubMed ID: 26615806
[TBL] [Abstract][Full Text] [Related]
9. An ultra-sensitive Abbott ARCHITECT
Lou S; Taylor R; Pearce S; Kuhns M; Leary T
J Clin Virol; 2018 Aug; 105():18-25. PubMed ID: 29843004
[TBL] [Abstract][Full Text] [Related]
10. [Evaluation and application of a newly developed highly sensitive HBsAg chemiluminescent enzyme immunoassay for chronic hepatitis B patients].
Shinkai N; Tanaka Y; Matsuura K; Kani S; Naganuma H; Mizokami M
Rinsho Byori; 2010 Nov; 58(11):1078-84. PubMed ID: 21229705
[TBL] [Abstract][Full Text] [Related]
11. [Development of Highly Sensitive Quantitative HBsAg Reagent and Its Availability].
Moriyama K; Isomura M
Rinsho Byori; 2015 Jan; 63(1):44-52. PubMed ID: 26524878
[TBL] [Abstract][Full Text] [Related]
12. Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors.
Kuhns MC; McNamara AL; Holzmayer V; Cloherty GA
Virol J; 2019 Apr; 16(1):43. PubMed ID: 30943997
[TBL] [Abstract][Full Text] [Related]
13. Clinical performance of the novel DiaSorin LIAISON(®) XL murex: HBsAg Quant, HCV-Ab, HIV-Ab/Ag assays.
Krawczyk A; Hintze C; Ackermann J; Goitowski B; Trippler M; Grüner N; Neumann-Fraune M; Verheyen J; Fiedler M
J Clin Virol; 2014 Jan; 59(1):44-9. PubMed ID: 24268764
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of clinical characteristics and S gene mutation of hepatitis B virus (HBV) in patients with hepatitis B surface antigen RIA negative and HBV DNA positive].
Sohn YH; Oh HB; Ko SY; Lim YS; Kwon OJ
Korean J Lab Med; 2009 Jun; 29(3):224-30. PubMed ID: 19571620
[TBL] [Abstract][Full Text] [Related]
15. Measurements in international units of antibody to hepatitis B surface antigen(anti-HBs) after immunization with a yeast-derived, subtype adr hepatitis B vaccine are considerably different between chemiluminescent immunoassay (CLIA) and chemiluminescent enzyme immunoassay (CLEIA).
Ogata N
Rinsho Byori; 2006 Apr; 54(4):340-3. PubMed ID: 16722452
[TBL] [Abstract][Full Text] [Related]
16. Quantitative detection of hepatitis B surface antigen by chemiluminescent microparticle immunoassay during lamivudine treatment of chronic hepatitis B virus carriers.
Kohmoto M; Enomoto M; Tamori A; Habu D; Takeda T; Kawada N; Sakaguchi H; Seki S; Shiomi S; Nishiguchi S
J Med Virol; 2005 Feb; 75(2):235-9. PubMed ID: 15602726
[TBL] [Abstract][Full Text] [Related]
17. Clinical performance of a new hepatitis B surface antigen quantitative assay with automatic dilution.
Liu TW; Yeh ML; Huang CF; Lin IL; Huang JF; Dai CY; Chen YL; Chuang WL; Yu ML
Kaohsiung J Med Sci; 2015 Jan; 31(1):26-33. PubMed ID: 25600917
[TBL] [Abstract][Full Text] [Related]
18. The Lumipulse G HBsAg-Quant assay for screening and quantification of the hepatitis B surface antigen.
Yang R; Song G; Guan W; Wang Q; Liu Y; Wei L
J Virol Methods; 2016 Feb; 228():39-47. PubMed ID: 26615803
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan Africa.
Boyd A; Maylin S; Moh R; Mahjoub N; Gabillard D; Eholié SP; Danel C; Anglaret X; Zoulim F; Girard PM; Delaugerre C; Lacombefor K;
J Gastroenterol Hepatol; 2016 Mar; 31(3):634-44. PubMed ID: 26313291
[TBL] [Abstract][Full Text] [Related]
20. Development of a highly sensitive bioluminescent enzyme immunoassay for hepatitis B virus surface antigen capable of detecting divergent mutants.
Minekawa T; Takehara S; Takahashi M; Okamoto H
Clin Vaccine Immunol; 2013 Aug; 20(8):1255-65. PubMed ID: 23761660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
